Research ExplorerResearch UnitsDepartment for Urology Publications

Department for Urology

1301 - 1350 out of 1,860Page size: 50
Sort by: Title

Publications

  1. Prognostic value of albumin to globulin ratio in non-muscle-invasive bladder cancer

    Quhal, F., Pradere, B., Laukhtina, E., Sari Motlagh, R., Mostafaei, H., Mori, K., Schuettfort, V. M., Karakiewicz, P. I., Rouprêt, M., Enikeev, D., Rink, M., Abufaraj, M. & Shariat, S. F., 09.2021, In: WORLD J UROL. 39, 9, p. 3345-3352 8 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  2. Prognostic value of alpha-methyl CoA racemase (AMACR) expression in renal cell carcinoma.

    Eichelberg, C., Minner, S., Isbarn, H., Burandt, E., Terracciano, L., Moch, H., Kell, A., Heuer, R., Chun, F. K., Sauter, G., Fisch, M. & Tennstedt, P., 2013, In: WORLD J UROL. 31, 4, p. 847-53 7 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  3. Prognostic value of Caveolin-1 in patients treated with radical prostatectomy: a multicentric validation study

    Mathieu, R., Klatte, T., Lucca, I., Beutcha, A. M., Seitz, C., Karakiewicz, P. I., Fajkovic, H., Sun, M., Lotan, Y., Scherr, D. S., Montorsi, F., Briganti, A., Rouprêt, M., Margulis, V., Rink, M., Kluth, L. A., Rieken, M., Kenner, L., Susani, M., Robinson, B. D., Xylinas, E., Loidl, W. & Shariat, S. F., 01.08.2016, In: BJU INT. 118, 2, p. 243-9

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  4. Prognostic value of hepatocyte growth factor for muscle-invasive bladder cancer

    Katayama, S., Schuettfort, V. M., Pradere, B., Mori, K., Mostafaei, H., Quhal, F., Sari Motlagh, R., Laukhtina, E., Grossmann, N. C., Aydh, A., Rajwa, P., König, F., Karakiewicz, P. I., Haydter, M., Moschini, M., Abufaraj, M., Lotan, Y., Lee, R. K., Trinh, Q-D., Compérat, E., Teoh, J., Nasu, Y. & Shariat, S. F., 11.2022, In: J CANCER RES CLIN. 148, 11, p. 3091-3102 12 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  5. Prognostic value of microvessel density in prostate cancer: a tissue microarray study.

    Erbersdobler, A., Isbarn, H., Dix, K., Steiner, I., Schlomm, T., Mirlacher, M., Sauter, G. & Haese, A., 2009, In: WORLD J UROL.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  6. Prognostic value of modified Glasgow Prognostic Score in non-muscle-invasive bladder cancer

    Kimura, S., D' Andrea, D., Soria, F., Foerster, B., Abufaraj, M., Vartolomei, M. D., Iwata, T., Karakiewicz, P. I., Rink, M., Gust, K. M., Egawa, S. & Shariat, S. F., 03.2019, In: UROL ONCOL-SEMIN ORI. 37, 3, p. 179.e19-179.e28

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  7. Prognostic value of perinodal lymphovascular invasion following radical cystectomy for lymph node-positive urothelial carcinoma

    Fritsche, H-M., May, M., Denzinger, S., Otto, W., Siegert, S., Giedl, C., Giedl, J., Eder, F., Agaimy, A., Novotny, V., Wirth, M., Stief, C., Brookman-May, S., Hofstädter, F., Gierth, M., Aziz, A., Kocot, A., Riedmiller, H., Bastian, P. J., Toma, M., Wieland, W. F., Hartmann, A. & Burger, M., 01.04.2013, In: EUR UROL. 63, 4, p. 739-44 6 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  8. Prognostic value of preoperative albumin to globulin ratio in patients treated with salvage radical prostatectomy for radiation recurrent prostate cancer

    Quhal, F., Pradere, B., Sari Motlagh, R., Mori, K., Laukhtina, E., Aydh, A., Mostafaei, H., Lysenko, I., Schuettfort, V. M., Stolzenbach, F., Palumbo, C., Heidenreich, A., Briganti, A., Karakiewicz, P. I., Chlosta, P. & Shariat, S. F., 10.2021, In: MINERVA UROL NEFROL. 73, 5, p. 610-615 6 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  9. Prognostic Value of Serum Cholinesterase in Non-muscle-invasive Bladder Cancer

    Kimura, S., Soria, F., D'Andrea, D., Foerster, B., Abufaraj, M., Vartolomei, M. D., Karakiewicz, P. I., Mathieu, R., Moschini, M., Rink, M., Egawa, S., Shariat, S. F. & Gust, K. M., 12.2018, In: CLIN GENITOURIN CANC. 16, 6, p. e1123-e1132

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  10. Prognostic value of the preoperative albumin-globulin ratio in patients with upper urinary tract urothelial carcinoma treated with radical nephroureterectomy: results from a large multicenter international collaboration

    Miura, N., Mori, K., Laukhtina, E., Schuettfort, V. M., Abufaraj, M., Teoh, J. Y. C., Luzzago, S., Stolzenbach, F., Deuker, M., Karakiewicz, P. I., Briganti, A., Enikeev, D. V., Rouprêt, M., Margulis, V., Chlosta, P., Nyirady, P., Babjuk, M., Egawa, S., Saika, T. & Shariat, S. F., 01.07.2021, In: JPN J CLIN ONCOL. 51, 7, p. 1149-1157 9 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  11. Prognostic value of the pre-operative serum albumin to globulin ratio in patients with non-metastatic prostate cancer undergoing radical prostatectomy

    Aydh, A., Mori, K., D'Andrea, D., Motlagh, R. S., Abufaraj, M., Pradere, B., Mostafaei, H., Laukhtina, E., Quhal, F., Karakiewicz, P. I., Luzzago, S., Briganti, A., Trinh, Q-D., Parizi, M. K., Tilki, D., Enikeev, D. V. & Shariat, S. F., 09.2021, In: INT J CLIN ONCOL. 26, 9, p. 1729-1735 7 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  12. Prognostic value of the systemic immune-inflammation index in non-muscle invasive bladder cancer

    Katayama, S., Mori, K., Pradere, B., Laukhtina, E., Schuettfort, V. M., Quhal, F., Motlagh, R. S., Mostafaei, H., Grossmann, N. C., Rajwa, P., Moschini, M., Mathieu, R., Abufaraj, M., D'Andrea, D., Compérat, E., Haydter, M., Egawa, S., Nasu, Y., Shariat, S. F. & European Association of Urology – Young Academic Urologists (EAU-YAU), Urothelial Carcinoma Working Group, 12.2021, In: WORLD J UROL. 39, 12, p. 4355-4361 7 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  13. Prognostische und prädiktive molekulare Marker urologischer Tumoren

    Hartmann, K. A., Schlomm, T., Bertz, S., Heinzelmann, J., Hölters, S., Simon, R., Stoehr, R. & Junker, K., 01.04.2014, In: UROLOGE. 53, 4, p. 491-500 10 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  14. Progression-free survival: does a correlation with survival justify its role as a surrogate clinical endpoint?

    Becker, A., Eichelberg, C. & Sun, M., 01.01.2014, In: CANCER J. 120, 1, p. 7-10 4 p.

    Research output: SCORING: Contribution to journal › Other (editorial matter etc.) › Research

  15. Promising role of preoperative neutrophil-to-lymphocyte ratio in patients treated with radical nephroureterectomy

    Vartolomei, M. D., Mathieu, R., Margulis, V., Karam, J. A., Rouprêt, M., Lucca, I., Mbeutcha, A., Seitz, C., Karakiewicz, P. I., Fajkovic, H., Wood, C. G., Weizer, A. Z., Raman, J. D., Rioux-Leclercq, N., Haitel, A., Bensalah, K., Rink, M., Briganti, A., Xylinas, E. & Shariat, S. F., 01.2017, In: WORLD J UROL. 35, 1, p. 121-130

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  16. Propensity-score matched comparison of complications, blood transfusions, length of stay, and in-hospital mortality between open and laparoscopic partial nephrectomy: a national series.

    Sun, M., Abdollah, F., Shariat, S. F., Schmitges, J., Trinh, Q-D., Tian, Z., Jeldres, C., Abdo, A., Bianchi, M., Briganti, A., Montorsi, F., Perrotte, P. & Karakiewicz, P. I., 2012, In: EJSO-EUR J SURG ONC. 38, 1, p. 80-87 1.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  17. Propensity-score-matched comparison of perioperative outcomes between open and laparoscopic nephroureterectomy: a national series.

    Hanna, N., Sun, M., Trinh, Q-D., Hansen, J., Bianchi, M., Montorsi, F., Shariat, S. F., Graefen, M., Perrotte, P. & Karakiewicz, P. I., 2012, In: EUR UROL. 61, 4, p. 715-721 4.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  18. Propensity-score-matched comparison of soft tissue surgical margins status between open and robotic-assisted radical cystectomy

    Moschini, M., Soria, F., Mathieu, R., Xylinas, E., D'Andrea, D., Tan, W. S., Kelly, J. D., Simone, G., Tuderti, G., Meraney, A., Krishna, S., Konety, B., Zamboni, S., Baumeister, P., Mattei, A., Briganti, A., Montorsi, F., Galucci, M., Rink, M., Karakiewicz, P. I., Rouprêt, M., Aziz, A., Perry, M., Rowe, E., Koupparis, A., Kassouf, W., Scherr, D. S., Ploussard, G., Boorjian, S. A., Sooriakumaran, P., Shariat, S. F. & European Association of Urology – Young Academic Urologists (EAU-YAU), Urothelial Carcinoma Working Group, 03.2019, In: UROL ONCOL-SEMIN ORI. 37, 3, p. 179.e1-179.e7

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  19. Prospective analysis of artificial urinary sphincter AMS 800 implantation after buccal mucosa graft urethroplasty.

    Maurer, V., Marks, P., Dahlem, R., Rosenbaum, C., Meyer, C., Riechardt, S., Fisch, M. & Ludwig, T. A., 17.01.2019, In: WORLD J UROL.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  20. Prospective head-to-head comparison of C-choline-PET/MR and C-choline-PET/CT for restaging of biochemical recurrent prostate cancer

    Eiber, M., Rauscher, I., Souvatzoglou, M., Maurer, T., Schwaiger, M., Holzapfel, K. & Beer, A. J., 12.2017, In: EUR J NUCL MED MOL I. 44, 13, p. 2179-2188 10 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research

  21. Prospective non-randomized evaluation of four mediators of the systemic response after extraperitoneal laparoscopic and open retropubic radical prostatectomy.

    Jurczok, A., Zacharias, M., Wagner, S., Hamza, A. & Fornara, P., 2007, In: BJU INT. 99, 6, p. 1461-1466 6.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  22. Prospective randomized double-blind multicentre phase II study comparing gemcitabine and cisplatin plus sorafenib chemotherapy with gemcitabine and cisplatin plus placebo in locally advanced and/or metastasized urothelial cancer. SUSE (AUO-AB 31/05)

    Krege, S., Rexer, H., vom Dorp, F., de Geeter, P., Klotz, T., Retz, M., Heidenreich, A., Kühn, M., Kamradt, J., Feyerabend, S., Wülfing, C., Zastrow, S., Albers, P., Hakenberg, O., Roigas, J., Fenner, M., Heinzer, H. & Schrader, M., 01.03.2014, In: BJU INT. 113, 3, p. 429-436 8 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  23. Prostatakarzinom - Langzeitwirksamkeit und - sicherheit von Degarelix

    Chun, F., 01.09.2014, In: AKTUEL UROL. 45, 5, p. 348-349 2 p.

    Research output: SCORING: Contribution to journal › Other (editorial matter etc.) › Research

  24. Prostatakarzinom--pN1: Sind wirklich alle Patienten gleich?

    Kluth, L. A. & Chun, F. K-H., 04.2016, In: AKTUEL UROL. 47, 02, p. 113-115 3 p.

    Research output: SCORING: Contribution to journal › Other (editorial matter etc.) › Research

  25. Prostataspezifische Membranantigen-Positronenemissionstomographie (PSMA-PET) für Urologen – wann und welcher Tracer?

    Berliner, C., Kesch, C., Fendler, W. P., Eiber, M. & Maurer, T., 04.2022, In: UROLOGE. 61, 4, p. 384-391 8 p.

    Research output: SCORING: Contribution to journal › SCORING: Review article › Research

  26. Prostate cancer-associated autoantibodies in serum against tumor-associated antigens as potential new biomarkers

    Ummanni, R., Duscharla, D., Barett, C., Venz, S., Schlomm, T., Heinzer, H., Walther, R., Bokemeyer, C., Brümmendorf, T. H., Murthy, P. V. L. N. & Balabanov, S., 24.04.2015, In: J PROTEOMICS. 119, p. 218-29 12 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  27. Prostate cancer detection and dutasteride: utility and limitations of prostate-specific antigen in men with previous negative biopsies.

    Leeuwen, V., Kölble, K., Huland, H., Huland, H., Hambrock, T., Barentsz, J. & Schröder, F. H., 2011, In: EUR UROL. 59, 2, p. 183-190 2.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  28. Prostate cancer diagnosis: importance of individualized risk stratification models over PSA alone.

    Chun, F., Karakiewicz, P. I. & Briganti, A., 2008, In: EUR UROL. 54, 2, p. 241-242 2.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  29. Prostate cancer gene 3 (PCA3): development and internal validation of a novel biopsy nomogram.

    Chun, F., de La Taille, A., van Poppel, H., Marberger, M., Stenzl, A., Mulders, P. F. A., Huland, H., Abbou, C-C., Stillebroer, A. B., Gils, V., Martijn, P. M. Q., Schalken, J. A., Fradet, Y., Marks, L. S., Ellis, W., Partin, A. W. & Haese, A., 2009, In: EUR UROL. 56, 4, p. 659-667 4.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  30. Prostate Cancer Grade and Stage Misclassification in Active Surveillance Candidates: Black Versus White Patients

    Stolzenbach, L. F., Rosiello, G., Pecoraro, A., Palumbo, C., Luzzago, S., Deuker, M., Tian, Z., Knipper, A-S., Pompe, R., Zorn, K. C., Shariat, S. F., Chun, F. K. H., Graefen, M., Saad, F. & Karakiewicz, P. I., 11.2020, In: J NATL COMPR CANC NE. 18, 11, p. 1492-1499 8 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  31. Prostate Cancer in Renal Transplant Recipients: Results from a Large Contemporary Cohort

    Marra, G., Soria, F., Peretti, F., Oderda, M., Dariane, C., Timsit, M-O., Branchereau, J., Hedli, O., Mesnard, B., Tilki, D., Olsburgh, J., Kulkarni, M., Kasivisvanathan, V., Lebacle, C., Rodriguez-Faba, O., Breda, A., Soeterik, T., Gandaglia, G., Todeschini, P., Biancone, L., Gontero, P. & On Behalf Of The Collaborators, 28.12.2022, In: CANCERS. 15, 1, 189.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  32. Prostate cancer in the elderly.

    Heinzer, H. & Steuber, T., 2009, In: UROL ONCOL-SEMIN ORI. 27, 6, p. 668-672 6.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  33. Prostate cancer risk, screening and management in patients with germline BRCA1/2 mutations

    Rajwa, P., Quhal, F., Pradere, B., Gandaglia, G., Ploussard, G., Leapman, M. S., Gore, J. L., Paradysz, A., Tilki, D., Merseburger, A. S., Morgan, T. M., Briganti, A., Palapattu, G. S. & Shariat, S. F., 04.2023, In: NAT REV UROL. 20, 4, p. 205-216 12 p.

    Research output: SCORING: Contribution to journal › SCORING: Review article › Research

  34. Prostate Health Index (Phi) and Prostate Cancer Antigen 3 (PCA3) significantly improve prostate cancer detection at initial biopsy in a total PSA range of 2-10 ng/ml

    Ferro, M., Bruzzese, D., Perdonà, S., Marino, A., Mazzarella, C., Perruolo, G., D'Esposito, V., Cosimato, V., Buonerba, C., Di Lorenzo, G., Musi, G., De Cobelli, O., Chun, F. K. & Terracciano, D., 01.01.2013, In: PLOS ONE. 8, 7, p. e67687

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  35. Prostate imaging-the future is now: current concepts and future potentials

    Chun, F. K-H. & Herrmann, T. R. W., 01.08.2014, In: WORLD J UROL. 32, 4, p. 843-845 3 p.

    Research output: SCORING: Contribution to journal › Other (editorial matter etc.) › Research

  36. Prostate-specific antigen and related isoforms in the diagnosis and management of prostate cancer.

    Haese, A., Graefen, M., Huland, H. & Lilja, H., 2004, In: CURR UROL REP. 5, 3, p. 231-240 3.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  37. [Prostate-specific antigen for treatment monitoring].

    Graefen, M., Fröhner, M. & Wirth, M., 2011, In: UROLOGE. 50, 3, p. 309-312 3.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  38. Prostate-specific antigen improves the ability of clinical stage and biopsy Gleason sum to predict the pathologic stage at radical prostatectomy in the new millennium.

    Chun, F., Briganti, A., Gallina, A., Hutterer, G. C., Shariat, S. F., Antebie, E., Walz, J., Roehrborn, C. G., Salonia, A., Rigatti, P., Saad, F., Huland, H., Montorsi, F., Graefen, M. & Karakiewicz, P. I., 2007, In: EUR UROL. 52, 4, p. 1067-1074 4.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  39. Prostate-Specific Antigen Level at the Time of Salvage Therapy After Radical Prostatectomy for Prostate Cancer and the Risk of Death

    Tilki, D., Chen, M-H., Wu, J., Huland, H., Graefen, M., Mohamad, O., Cowan, J. E., Feng, F. Y., Carroll, P. R. & D'Amico, A. V., 01.05.2023, In: J CLIN ONCOL. 41, 13, p. 2428-2435 8 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  40. Prostate-specific antigen levels of ≤4 and >4 ng/mL and risk of prostate cancer-specific mortality in men with biopsy Gleason score 9 to 10 prostate cancer

    Kim, D. W., Chen, M-H., Wu, J., Huland, H., Graefen, M., Tilki, D. & D'Amico, A. V., 01.07.2021, In: CANCER-AM CANCER SOC. 127, 13, p. 2222-2228 7 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  41. Prostate-Specific Membrane Antigen-Guided Surgery

    Maurer, T., Graefen, M., van der Poel, H., Hamdy, F., Briganti, A., Eiber, M., Wester, H-J. & van Leeuwen, F. W. B., 01.2020, In: J NUCL MED. 61, 1, p. 6-12 7 p.

    Research output: SCORING: Contribution to journal › SCORING: Review article › Research

  42. Prostate-Specific Membrane Antigen Ligands for Imaging and Therapy: J Nucl Med

    Eiber, M., Fendler, W. P., Rowe, S. P., Calais, J., Hofman, M. S., Maurer, T., Schwarzenboeck, S. M., Kratowchil, C., Herrmann, K. & Giesel, F. L., 2017, In: J NUCL MED. 58, Suppl 2, p. 67s-76s

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research

  43. Prostate-specific Membrane Antigen Positron Emission Tomography as a Biomarker to Assess Treatment Response in Patients with Advanced Prostate Cancer

    Esen, B., Herrmann, K., Bavbek, S., Kordan, Y., Tilki, D. & Esen, T., 07.2023, In: EUR UROL FOCUS. 9, 4, p. 596-605 10 p.

    Research output: SCORING: Contribution to journal › SCORING: Review article › Research

  44. Prostate-specific Membrane Antigen Radioguidance for Salvage Lymph Node Dissection in Recurrent Prostate Cancer

    Knipper, S., Budäus, L., Graefen, M. & Maurer, T., 03.2021, In: EUR UROL FOCUS. 7, 2, p. 294-296 3 p.

    Research output: SCORING: Contribution to journal › Other (editorial matter etc.) › Research

  45. Prostate-specific Membrane Antigen-radioguided Surgery Facilitates Pelvic Lymph Node Dissection During Radical Prostatectomy for the Treatment of Locally Advanced Prostate Cancer with Regional Lymph Node Metastases

    Lunger, L., Steinhelfer, L., Korn, P., Eiber, M., Maurer, T., Büchler, J., Horn, T., Gschwend, J. E. & Heck, M. M., 02.2023, In: EUR UROL ONCOL. 6, 1, p. 95-98 4 p.

    Research output: SCORING: Contribution to journal › Short publication › Research › peer-review

  46. Prostate-specific membrane antigen radioguided surgery with negative histopathology

    Koehler, D., Trappe, S., Shenas, F., Karimzadeh, A., Apostolova, I., Klutmann, S., Ambrosini, F., Budäus, L., Falkenbach, F., Knipper, S. & Maurer, T., 01.2024, In: EUR J NUCL MED MOL I. 51, 2, p. 548-557 10 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  47. Prostate volume and adverse prostate cancer features: fact not artifact.

    Briganti, A., Chun, F., Suardi, N., Gallina, A., Walz, J., Graefen, M., Shariat, S., Ebersdobler, A., Rigatti, P., Perrotte, P., Saad, F., Montorsi, F., Huland, H. & Karakiewicz, P. I., 2007, In: EUR J CANCER. 43, 18, p. 2669-2677 18.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  48. Prostatic Artery Embolization versus Standard Surgical Treatment for Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia: A Systematic Review and Meta-analysis

    Zumstein, V., Betschart, P., Vetterlein, M. W., Kluth, L. A., Hechelhammer, L., Mordasini, L., Engeler, D. S., Kessler, T. M., Schmid, H-P. & Abt, D., 11.2019, In: EUR UROL FOCUS. 5, 6, p. 1091-1100 10 p.

    Research output: SCORING: Contribution to journal › SCORING: Review article › Research

  49. Prostatic volume and ratio of free-to-total prostate specific antigen in patients with prostatic cancer or benign prostatic hyperplasia.

    Haese, A., Graefen, M., Noldus, J., Hammerer, P., Huland, E. & Huland, H., 1997, In: J UROLOGY. 158, 6, p. 2188-2192 6.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  50. Protocol-based active surveillance for low-risk prostate cancer: anxiety levels in both men and their partners.

    Seiler, D., Randazzo, M., Leupold, U., Zeh, N., Isbarn, H., Chun, F., Ahyai, S., Baumgartner, M., Huber, A., Recker, F. & Kwiatkowski, M., 2012, In: UROLOGY. 80, 3, p. 564-569 3.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

Previous 1...23 24 25 26 27 28 29 30 ...38 Next